Penumbra, Inc Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Penumbra, Inc (PEN) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$19.26 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-02-23
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was $9.30M, a 43.89% increase year-over-year.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was $11.00M.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was $16.25M, a 11.21% increase year-over-year.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was $10.45M, a 62.28% increase year-over-year.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$19.26M, a 140.97% decline from fiscal 2019.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was $47.00M, a 681.97% increase from fiscal 2018.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was $6.01M, a 1.25% decline from fiscal 2017.
- Penumbra, Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was $6.09M, a 58.91% decline from fiscal 2016.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$19.26M 10-K · filed 2021-02-23 | |||
| 2019-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $20.30M derived: sum of 2 quarters · filed 2021-02-23 | $36.55M derived: sum of 3 quarters · filed 2021-02-23 | $47.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | $11.00M 10-Q · filed 2019-11-07 | $27.25M derived: sum of 2 quarters · filed 2019-11-07 | $37.70M 10-Q · filed 2019-11-07 | $44.17M derived: sum of 4 quarters · filed 2020-02-26 |
| 2019-06-30 | $16.25M 10-Q · filed 2019-08-06 | $26.70M 10-Q · filed 2019-08-06 | $33.17M derived: sum of 3 quarters · filed 2020-02-26 | $11.66M derived: sum of 4 quarters · filed 2020-02-26 |
| 2019-03-31 | $10.45M 10-Q · filed 2019-05-07 | $16.92M derived: sum of 2 quarters · filed 2020-02-26 | -$4.59M derived: sum of 3 quarters · filed 2020-02-26 | $10.02M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-12-31 | $6.46M 10-K · filed 2020-02-26 | -$15.04M derived: sum of 2 quarters · filed 2020-02-26 | -$431.00K derived: sum of 3 quarters · filed 2020-02-26 | $6.01M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$21.51M 10-K · filed 2020-02-26 | -$6.89M derived: sum of 2 quarters · filed 2020-02-26 | -$453.00K 10-Q · filed 2019-11-07 | $9.36M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $14.61M 10-K · filed 2020-02-26 | $21.05M 10-Q · filed 2019-08-06 | $30.86M derived: sum of 3 quarters · filed 2020-02-26 | $31.65M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $6.44M 10-K · filed 2020-02-26 | $16.25M derived: sum of 2 quarters · filed 2020-02-26 | $17.04M derived: sum of 3 quarters · filed 2020-02-26 | $15.63M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $9.81M 10-K · filed 2019-02-26 | $10.59M derived: sum of 2 quarters · filed 2019-02-26 | $9.19M derived: sum of 3 quarters · filed 2019-02-26 | $6.09M 10-K · filed 2020-02-26 |
| 2017-09-30 | $783.00K 10-K · filed 2019-02-26 | -$617.00K derived: sum of 2 quarters · filed 2019-02-26 | -$3.72M 10-Q · filed 2018-11-05 | -$6.12M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$1.40M 10-K · filed 2019-02-26 | -$4.51M 10-Q · filed 2018-08-07 | -$6.90M derived: sum of 3 quarters · filed 2019-02-26 | $5.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$3.11M 10-K · filed 2019-02-26 | -$5.50M derived: sum of 2 quarters · filed 2019-02-26 | $6.40M derived: sum of 3 quarters · filed 2019-02-26 | $9.42M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$2.40M 10-K · filed 2018-02-27 | $9.51M derived: sum of 2 quarters · filed 2018-02-27 | $12.52M derived: sum of 3 quarters · filed 2018-02-27 | $14.81M 10-K · filed 2019-02-26 |
| 2016-09-30 | $11.91M 10-K · filed 2018-02-27 | $14.92M derived: sum of 2 quarters · filed 2018-02-27 | $17.21M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-06-30 | $3.01M 10-K · filed 2018-02-27 | $5.30M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $2.29M 10-K · filed 2018-02-27 | |||
| 2015-12-31 | $2.37M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |